Previous 10 | Next 10 |
Thomson Reuters ONE news releases related Thomson Reuters One news releases and Thomson Reuters One press releases from 09/23/19 09:01:00 on US and Canada...
SOUTHBOROUGH, Mass., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Virtusa Corporation (NASDAQ GS:VRTU), a global provider of digital strategy, digital engineering and IT services and solutions that help clients change and disrupt markets through innovation engineering, ann...
FAIRFIELD, Conn., Sept. 23, 2019 (GLOBE NEWSWIRE) -- September 20, 2019 On September 20, 2019, General Electric Company (the "Company") filed a Form 8-K with the U.S. Securities and Exchange Commission ("SEC"), which has been submitted to RNS. It is also available on the SEC's...
AUSTIN, Texas, Sept. 20, 2019 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today that the Canadian Patent Office has granted XBiotech a patent (Patent Number 56003542-6CA) covering the use of bermekimab in the treatment of inflammatory skin diseases. The patent describes studies ...
GAITHERSBURG, Md., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that Stanley C. Erck, President and Chief Executive Officer, will present at the Ladenburg...
WESTCHESTER, Ill., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Today, the Board of Directors of Ingredion Incorporated (NYSE: INGR) declared a quarterly dividend of $0.63 per share on the company’s common stock. The dividend is payable on October 25, 2019, to stockholders of record at the ...
DEVOTE trial to evaluate safety and even greater efficacy of a higher dose of SPINRAZA in the treatment of SMA; well-established safety profile supports exploration of potential benefits Long-term data from the SHINE study demonstrate improvements in or stabilization of motor function in pat...
Conference call and webcast on Wednesday, September 18 at 2:30 pm CET/8:30 am EDT TRYbeCA1, Phase 3 trial for eryaspase in second line pancreatic cancer, progressing on plan Immune modulation collaboration entered into with SQZ Biotechnologies Board strengthened with appointment of D...
CAMBRIDGE, Mass., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that it has been ranked the #1 biotechnology company on the Dow Jones Sustainability World Index (DJSI World) for the fourth time, after being the first U.S.-based biotech company to ever mak...
Presentations to highlight low-code development’s role in Marcus by Goldman Sachs customer service operations and SWIFT gpi cross-border payment solution TYSONS, Va., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Appian (NASDAQ: APPN) today announced a packed line-up for its participation at Si...
VANCOUVER, British Columbia, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLL) (OTC-Nasdaq Intl. Designation: STLHF) (FRA: S5L), announced that its CEO Robert Mintak, will be joining host Sam Jaffe of Cairn ER...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
8.25%Change Percent:
Sotera Health Company Company Name:
SHC Stock Symbol:
NASDAQ Market:
investors.soterahealth.com Website: